IBER.WS
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
IBER.WS
Delisted
IBER.WS was delisted on the 15th of February, 2023.
30 hedge funds and large institutions have $3.74M invested in Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
Holders
30
Holding in Top 10
–
Calls
$2.22M
Puts
–
Top Buyers
| 1 | +$107K | |
| 2 | +$67K | |
| 3 | +$53K | |
| 4 |
Walleye Capital
New York
|
+$29K |
| 5 |
Walleye Trading
New York
|
+$22K |